These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11847403)

  • 1. The GUSTO-V clinical trial.
    Lincoff AM
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():21A-30A. PubMed ID: 11847403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
    Antman EM; Van de Werf F
    Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological reperfusion in acute myocardial infarct].
    Lorenzoni R; Gensini GF; De Caterina R
    G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: an emerging solution for reperfusion.
    Kaplan AL; Goldmann B; Ohman EM
    J Emerg Med; 1999; 17(3):589-95. PubMed ID: 10338261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute myocardial infarction: thrombolysis].
    Branzi A; Ortolani P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):711-5. PubMed ID: 12497809
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.
    de Lemos J
    Md Med; 2001; Suppl():88-9. PubMed ID: 11434069
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological and mechanical revascularization strategies in STEMI: integration of the two approaches.
    Pollack C
    J Invasive Cardiol; 2008 May; 20(5):231-8. PubMed ID: 18460708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
    Gabriel RS; White HD
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies.
    Goldstein P; Lapostolle F; Steg G; Danchin N; Assez N; Montalescot G; Charpentier S; Wiel E; Juliard JM
    Eur J Emerg Med; 2009 Oct; 16(5):244-55. PubMed ID: 19318957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives].
    Hoefnagels WA
    Ned Tijdschr Geneeskd; 2005 Feb; 149(9):498; author reply 498. PubMed ID: 15771351
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acute myocardial infarction: the best reperfusion strategy. Opinion of the clinical cardiologist].
    Savonitto S; Schirru M; Fusco R; Klugmann S
    Ital Heart J; 2002 Oct; 3 Suppl 6():9S-17S. PubMed ID: 12422807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
    Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.
    Sabatine MS; McCabe CH; Gibson CM; Cannon CP
    Am Heart J; 2005 Feb; 149(2):227-33. PubMed ID: 15846259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.